iMeds.se

Fexofenadin Cipla

Information för alternativet: Fexofenadin Cipla 180 Mg Filmdragerad Tablett, visa andra alternativ
Document: Fexofenadin Cipla 180 mg film-coated tablet ENG PL change

Package leaflet: Information for the patient

Fexofenadine Cipla 180 mg film-coated tablets

fexofenadine hydrochloride


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.



What is in this leaflet

What Fexofenadine Cipla is and what it is used for

What you need to know before you take Fexofenadine Cipla

How to take Fexofenadine Cipla

Possible side effects

How to store Fexofenadine Cipla

Contents of the pack and other information


What Fexofenadine Cipla is and what it is used for


Fexofenadine Cipla contains fexofenadine hydrochloride, which is an antihistamine.


Fexofenadine Cipla 180 mg is used in adults and adolescents of 12 years and older to relieve the symptoms that occur with long term allergic skin reactions (chronic idiopathic urticaria) such as itching, swelling and rashes.


What you need to know before you take Fexofenadine Cipla


Do not take Fexofenadine Cipla:

if you are allergic to fexofenadine or any of the other ingredients of this medicine (listed in section 6).


Warnings and precautions

Talk to your doctor, pharmacist or nurse before taking Fexofenadine Cipla.


Tell your doctor, pharmacist or nurse especially if:


Children and adolescents

Fexofenadine Cipla 180 mg film-coated tablet is not recommended in children and adolescents below 12 years of age.


Other medicines and Fexofenadine Cipla

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.


Indigestion remedies containing aluminium and magnesium may affect the action of Fexofenadine Cipla, by lowering the amount of medicinal product absorbed.


It is recommended that you leave about 2 hours between the time that you take Fexofenadine Cipla and your indigestion remedy.


Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.


Do not take Fexofenadine Cipla if you are pregnant, unless necessary.

Fexofenadine Cipla is not recommended during breast-feeding.


Driving and using machines

Fexofenadine Cipla is unlikely to affect your ability to drive or operatemachinery. However, you should check that these tablets donot make you feel sleepy or dizzy before driving or operatingmachinery.


How to take Fexofenadine Cipla

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.


For adults and adolescents aged 12 years and over

The recommended dose is one tablet (180 mg) daily.


Take your tablet with water before a meal.


Use in children and adolescents

Fexofenadine Cipla 180 mg film-coated tablet is not recommended in children and adolescents below 12 years of age.


If you take more Fexofenadine Cipla than you should

If you take too many tablets, contact your doctor or the nearest hospital emergency department immediately.


Symptoms of an overdose in adults are dizziness, drowsiness, fatigue and dry mouth.


If you forget to take Fexofenadine Cipla

Do not take a double dose to make up for a forgotten tablet.

Take the next dose at the usual time as prescribed by your doctor.


If you stop taking Fexofenadine Cipla

Tell your doctor if you want to stop taking Fexofenadine Cipla before you have finished your course of treatment.


If you stop taking Fexofenadine Cipla earlier than planned, yoursymptoms may return.


If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


Tell your doctor immediately and stop taking Fexofenadine Cipla if you experience:

Swelling of the face, lips, tongue or throat and difficulty breathing, as these may be signs of a serious allergic reaction.


Common side effects (may affect up to 1 in 10 people):


Uncommon side effects(may affect up to 1 in 100 people):


Additional side effects(frequency not known: cannot beestimated from the available data) which may occur are:


Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.


[ To be completed nationally ]


How to store Fexofenadine Cipla


Keep this medicine out of the sight and reach of children.


Do not use this medicine after the expiry date which is statedon the carton/label/blister after EXP. The expiry date refers to the last dayof that month.


This medicine does not require any special storage condition.


Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use.These measures will helpprotect the environment.


Contents of the pack and other information


What Fexofenadine Cipla contains:

The active substance is fexofenadine hydrochloride. Each tablet contains 180 mg of fexofenadine hydrochloride.



Film coating: hypromellose, titanium dioxide (E171), macrogol, iron oxide yellow (E172)


What Fexofenadine Cipla looks like and contents of the pack


Fexofenadine Cipla 180 mg film-coated tablets areyellow coloured, oblong, film-coated tablets plain on one side with a central score line on the other side. Dimensions: 17.00 x 8.00 mm


PVC/PVDC/Al blisters, packaged into cardboard boxes. 10, 15, 20, 30, 50, 100 and 200 (as 10x20) tablets per package.


Not all packs sizes may be marketed


This medicinal product is authorised in the Member States of the EEA under the following names

Sweden: Fexofenadine Cipla

Germany: Fexofenadinhydrochlorid Cipla 180 mg Filmtabletten

Denmark: Fexofenadinhydrochlorid Cipla

Spain: Fexofenadina Cipla 180 mg Comprimido recubierto con película

France: FEXOFENADINE CIPLA 180 mg, comprimé pelliculé

Finland: Feksofenadiini Cipla

Croatia: Feksofenadinklorid Cipla 180 mg filmomobložene tablete

Hungary: Fexofenadin Cipla 180 mg filmtabletta

Italy: Fexofenadina Cipla

Norway: Feksofenadin Cipla

Poland: Fexofenadine hydrochloride Cipla

Portugal: Fexofenadina cloridrato Cipla

Slovenia: Feksofenadinijev klorid Cipla 180 mg filmsko obložene tablete


Marketing Authorisation Holder

Cipla Europe NV

Uitbreidingstraat 80, 2600 Antwerp, Belgium


Manufacturer

S&D Pharma CZ,

spol. sr.o, Theodor 28, Pchery (Pharmosa.s. facility), 27308, CeskáRepublika


Cipla (EU) Limited

20 Balderton Street, London W1K 6TL, United Kingdom


Cipla Europe NV, Uitbreidingstraat 80, 2600 Antwerp, Belgium


This leaflet was last revised in 2015-09-02